Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Idt Biologika
Pharmaceutical Preparation ManufacturingUnited States
Last verified 12 days agoidt-biologika.com
IDT Biologika, a renowned global biopharmaceutical company often referred to simply as IDT, is headquartered in Dessau-Roßlau, Germany, with a significant operational presence across Europe and North America, including the US. Established in 1921, IDT Biologika boasts over a century of expertise in pharmaceutical preparation manufacturing.
Specialising as a Contract Development and Manufacturing Organisation (CDMO), IDT Biologika provides comprehensive, end-to-end services for developing and producing human vaccines, veterinary vaccines, gene and cell therapies, and other complex biologics. Their unique dual capability as both a CDMO and an innovative developer of proprietary vaccines positions them as a trusted partner in global health solutions. This rich history and deep scientific knowledge ensure the delivery of high-quality, safe, and effective biopharmaceutical products, contributing significantly to public and animal health programmes worldwide.
46
DitchCarbon score
+4 vs industry average
Idt Biologika’s score of 46 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Idt Biologika?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Idt Biologika's reported carbon emissions
In 2024, IDT Biologika reported its Scope 1 emissions as 8,808,950 kg CO2e and its Scope 2 emissions as 6,369,670 kg CO2e. For 2023, the pharmaceutical manufacturer disclosed Scope 1 emissions of 8,419,330 kg CO2e and Scope 2 emissions of 7,209,210 kg CO2e. In 2021, the company's Scope 1 emissions were 8,443,450 kg CO2e, and Scope 2 emissions were 12,228,900 kg CO2e. There is no publicly available Scope 3 emissions data for any reported year.
IDT Biologika has committed to reducing its CO2e emissions by 3% per year for both Scope 1 and Scope 2 in 2023 and 2024. While the company previously had a net-zero commitment, its status with the Science Based Targets initiative (SBTi) currently indicates that this commitment has been removed. All disclosed emissions data and reduction targets are directly from IDT Biologika GmbH.
Assessing Idt Biologika as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Idt Biologika and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Idt Biologika’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
Inherited from SK Chemicals Co.,LtdSee details
Active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Idt Biologika12 days ago
46
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Idt Biologika’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more